Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2012 1
2013 1
2014 1
2016 1
2017 2
2018 1
2019 3
2020 2
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas.
Liebers N, Duell J, Fitzgerald D, Kerkhoff A, Noerenberg D, Kaebisch E, Acker F, Fuhrmann S, Leng C, Welslau M, Chemnitz J, Middeke JM, Weber T, Holtick U, Trappe R, Pfannes R, Liersch R, Spoer C, Fuxius S, Gebauer N, Caillé L, Geer T, Koenecke C, Keller U, Claus R, Mougiakakos D, Mayer S, Huettmann A, Pott C, Trummer A, Wulf G, Brunnberg U, Bullinger L, Hess G, Mueller-Tidow C, Glass B, Lenz G, Dreger P, Dietrich S. Liebers N, et al. Among authors: brunnberg u. Blood Adv. 2021 Jul 13;5(13):2707-2716. doi: 10.1182/bloodadvances.2020004155. Blood Adv. 2021. PMID: 34196677 Free PMC article.
HIV-Associated Malignant Lymphoma.
Brunnberg U, Hentrich M, Hoffmann C, Wolf T, Hübel K. Brunnberg U, et al. Oncol Res Treat. 2017;40(3):82-87. doi: 10.1159/000456036. Epub 2017 Feb 24. Oncol Res Treat. 2017. PMID: 28253516 Free article. Review.
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas.
Hartmann S, Scharf S, Steiner Y, Loth AG, Donnadieu E, Flinner N, Poeschel V, Angel S, Bewarder M, Bein J, Brunnberg U, Bozzato A, Schick B, Stilgenbauer S, Bohle RM, Thurner L, Hansmann ML. Hartmann S, et al. Among authors: brunnberg u. Cancers (Basel). 2021 Oct 17;13(20):5208. doi: 10.3390/cancers13205208. Cancers (Basel). 2021. PMID: 34680356 Free PMC article.
Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation.
Weber S, Scheich S, Magh A, Wolf S, Enßle JC, Brunnberg U, Reinheimer C, Wichelhaus TA, Kempf VAJ, Kessel J, Vehreschild MJGT, Serve H, Bug G, Steffen B, Hogardt M. Weber S, et al. Among authors: brunnberg u. Int J Infect Dis. 2020 Oct;99:428-436. doi: 10.1016/j.ijid.2020.08.030. Epub 2020 Aug 12. Int J Infect Dis. 2020. PMID: 32798661 Free article.
Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma.
Topp MS, Eradat H, Florschütz A, Hochhaus A, Wrobel T, Walewski J, Knopinska-Posluszny W, Kanate AS, Lech-Maranda E, Brunnberg U, Chitra S, Nielsen TG, Sellam G, Shivhare M, Lossos IS. Topp MS, et al. Among authors: brunnberg u. J Cancer Res Clin Oncol. 2022 Feb 18. doi: 10.1007/s00432-021-03847-5. Online ahead of print. J Cancer Res Clin Oncol. 2022. PMID: 35182224
Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy.
Ballo O, Kreisel EM, Eladly F, Brunnberg U, Stratmann J, Hunyady P, Hogardt M, Wichelhaus TA, Kempf VAJ, Steffen B, Vehreschild JJ, Vehreschild MJGT, Finkelmeier F, Serve H, Brandts CH. Ballo O, et al. Among authors: brunnberg u. Ann Hematol. 2020 Nov;99(11):2547-2553. doi: 10.1007/s00277-020-04274-1. Epub 2020 Sep 24. Ann Hematol. 2020. PMID: 32974837 Free PMC article. Clinical Trial.
18 results